Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study.
BACKGROUND
Little is known on the impact of travel vaccinations during pregnancy on child outcomes, in particular on the long-term psychomotor development. The objectives of the study were (1) to estimate the rate of premature births, congenital abnormalities, and mental and physical development problems of children born from mothers who had been vaccinated during pregnancy and (2) to compare these rates with those of children whose mothers had not been vaccinated during pregnancy.


METHODS
Longitudinal study including (1) retrospectively pregnant women having attended our travel clinic before (vaccinated) and (2) prospectively mothers attending our clinic (nonvaccinated). We performed phone interviews with mothers vaccinated during pregnancy, up to 10 years before, and face-to-face interviews with nonvaccinated age-matched mothers, ie, women attending the travel clinic who had one child of about the same age as the one of the case to compare child development between both groups.


RESULTS
Fifty-three women vaccinated during pregnancy were interviewed as well as 53 nonvaccinated ones. Twenty-eight (53%) women received their vaccination during the first trimester. The most frequent vaccine administered was hepatitis A (55% of the cases), followed by di-Te (34%), IM poliomyelitis (23%), yellow fever (12%), A-C meningitis (8%), IM typhoid (4%), and oral poliomyelitis (4%). Children were followed for a range of 1 to 10 years. Rates of premature births were 5.7% in both groups; congenital abnormalities were 1.9% in the vaccinated cohort versus 5.7% in the nonvaccinated one; children took their first steps at a median age of 12 months in both cohorts; among schoolchildren, 5% of the vaccinated cohort versus 7.7% of the nonvaccinated attended a lower level or a specialized school.


CONCLUSIONS
In this small sample size, there was no indication that usual travel vaccinations, including the yellow fever one, had deleterious effect on child outcome and development.
D'Acremont
Valérie
V
Travel Clinic, Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
Tremblay
Sylvie
S
Genton
Blaise
B
D000328:Adult; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D003140:Communicable Disease Control / Q000379:methods; D003141:Communicable Diseases / Q000635:transmission; D000013:Congenital Abnormalities / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007231:Infant, Newborn; D007239:Infections / Q000635:transmission*; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control* / Q000706:statistics & numerical data; D008137:Longitudinal Studies; D008425:Maternal Behavior; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000517:prevention & control*; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D013557:Switzerland / Q000453:epidemiology; D014195:Travel / Q000706:statistics & numerical data*; D014765:Viral Vaccines / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission*
D001428:Bacterial Vaccines; D014765:Viral Vaccines